![](/img/cover-not-exists.png)
Rictor/mTORC2 drives progression and therapeutic resistance of HER2-amplified breast cancers
Morrison-Joly, M., Hicks, D. J., Jones, B., Sanchez, V., Estrada, M. V., Young, C., Williams, M., Rexer, B. N., Sarbassov, D. D., Muller, W. J., Brantley-Sieders, D., Cook, R. S.Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-15-3393
Date:
April, 2016
File:
PDF, 3.33 MB
english, 2016